Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2015 | 09-2015 | 07-2015 | 06-2015 | 04-2015 | |
| Sales | 0 | 0 | 0 | 49 | 0 |
| Gross Profit | N/A | N/A | N/A | 49 | N/A |
| Operating Expenses | 3,749 | 3,104 | 3,115 | 4,916 | 0 |
| Operating Income | -3,749 | -3,104 | -3,115 | -4,867 | N/A |
| Interest Expense | 0 | 1 | 1 | 1 | 0 |
| Other Income | 225 | 184 | 81 | 121 | 0 |
| Pre-tax Income | -3,524 | -2,921 | -3,035 | -4,748 | 0 |
| Net Income Continuous | -3,524 | -2,921 | -3,035 | -4,748 | N/A |
| Net Income | $-3,524 | $-2,921 | $-3,035 | $-4,748 | $N/A |
| EPS Basic Total Ops | -4,160.00 | -3,200.00 | -3,520.00 | -5,440.00 | N/A |
| EPS Basic Continuous Ops | -4,010.67 | -3,323.56 | -3,453.20 | -5,403.20 | N/A |
| EPS Diluted Total Ops | -4,160.00 | -3,200.00 | -3,520.00 | -5,440.00 | N/A |
| EPS Diluted Continuous Ops | -4,010.67 | -3,323.56 | -3,453.20 | -5,403.20 | N/A |
| EBITDA(a) | $-3,218 | $-3,346 | $-3,357 | $-4,893 | $N/A |